Enliven Therapeutics shares owned by Capital Research Global Investors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Capital Research Global Investors
from 13F filings
Historical chart of Capital Research Global Investors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Capital Research Global Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Capital Research Global Investors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $27M | 1.3M | 20.47 |
| 2025-06-30 | $26M | 1.3M | 20.06 |
More positions owned by Capital Research Global Investors
View all positions for Capital Research Global Investors